Ohcanbohtosat - Guolin Zhao
- Čájehuvvo 1 - 4 / 4
-
1
Inhaled siRNA nanoparticles targeting <i>IL11</i> inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge Dahkki Xin Bai, Guolin Zhao, Qijing Chen, Zhongyu Li, Mingzhu Gao, William Ho, Xiaoyang Xu, Xue‐Qing Zhang
Almmustuhtton 2022Artigo -
2
Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms Dahkki Tao Wang, Zhixing Zhou, Lixin Sun, Xia Li, Zhimeng Xu, Chen Mi, Guolin Zhao, Zhenzhou Jiang, Luyong Zhang
Almmustuhtton 2014Artigo -
3
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial Dahkki Robert E. MacLaren, Manuel Fischer, James A. Gow, Byron L. Lam, Eeva-Marja Sankila, Aniz Girach, Sushil Panda, Dan Yoon, Guolin Zhao, Mark E. Pennesi
Almmustuhtton 2023Artigo -
4
Neurofilament as a potential biomarker for spinal muscular atrophy Dahkki Basil T. Darras, Thomas O. Crawford, Richard S. Finkel, Eugenio Mercuri, Darryl C. De Vivo, Maryam Oskoui, Eduardo F. Tizzano, Monique M. Ryan, Francesco Muntoni, Guolin Zhao, John F. Staropoli, Alexander McCampbell, Marco Petrillo, Christopher Stebbins, Stephanie Fradette, Wildon Farwell, Charlotte J. Sumner
Almmustuhtton 2019Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Internal medicine
Medicine
Chemistry
Endocrinology
Adverse effect
Atrophy
Bile acid
Biochemistry
Biomarker
Bleomycin
Cancer research
Chemotherapy
Cholestasis
Choroideremia
Clinical endpoint
Clinical trial
Combinatorics
Cystic fibrosis
Diabetes mellitus
Diabetic retinopathy
Disease
Fibrosis
Gastroenterology
Idiopathic pulmonary fibrosis
Immunohistochemistry
Liver injury
Lung
Mathematics
Myofibroblast
Neurofilament